SCHEMBL31477993

SCHEMBL31477993

N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.69
ACE P12821 2/20 0.68
MME P08473 1/20 0.66
ALOX15 P16050 1/20 0.66
ECE1 P42892 3/20 0.63
KDM4E B2RXH2 1/20 0.63
MEN1 O00255 1/20 0.63
LMNA P02545 1/20 0.63
MPO P05164 1/20 0.63
MAPT P10636 1/20 0.63
TSHR P16473 1/20 0.63
BLM P54132 1/20 0.63
PMP22 Q01453 1/20 0.63
KMT2A Q03164 1/20 0.63
HIF1A Q16665 1/20 0.63
ERAP2 Q6P179 1/20 0.62
ERAP1 Q9NZ08 1/20 0.62
LNPEP Q9UIQ6 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28067637 1.00 LTA4H (0.69) LTA4HACEMMEALOX15ECE1
SCHEMBL11853752 1.00 LTA4H (0.69) LTA4HACEMMEALOX15ECE1
SCHEMBL28067636 1.00 LTA4H (0.69) LTA4HACEMMEALOX15ECE1
SCHEMBL30557742 1.00 LTA4H (0.69) LTA4HACEMMEALOX15ECE1
SCHEMBL2182644 1.00 LTA4H (0.69) LTA4HACEMMEALOX15ECE1
SCHEMBL11873462 1.00 LTA4H (0.69) LTA4HACEMMEALOX15ECE1
SCHEMBL31619984 1.00 LTA4H (0.69) LTA4HACEMMEALOX15ECE1
SCHEMBL11873471 1.00 LTA4H (0.69) LTA4HACEMMEALOX15ECE1
SCHEMBL2182648 1.00 LTA4H (0.69) LTA4HACEMMEALOX15ECE1
SCHEMBL29577413 0.98 LTA4H (0.66) LTA4HACEMMEALOX15ECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119792557-A Polypeptide coupling medicine of somatostatin receptor binding peptide coupled TLR agonist and preparation method thereof 深圳威科森生物医药科技有限公司 2025-04-11 CN disclosed